These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 1834451)
1. New drugs for hypertension--variations on old themes. Drug Ther Bull; 1991 Mar; 29(6):21-2. PubMed ID: 1834451 [No Abstract] [Full Text] [Related]
2. [New specialty drugs registered in Austria. Supressin]. Ganzinger U Wien Klin Wochenschr; 1989 Oct; 101(20):714-20. PubMed ID: 2531501 [No Abstract] [Full Text] [Related]
3. [New hypotensive drugs]. Sznajderman M Pol Tyg Lek; 1984 Dec 17-31; 39(51-52):1695-700. PubMed ID: 6097887 [No Abstract] [Full Text] [Related]
4. Doxazosin for treatment of hypertension. Med Lett Drugs Ther; 1991 Feb; 33(838):15-6. PubMed ID: 1825232 [No Abstract] [Full Text] [Related]
5. Slow-release isradipine in mild to moderate hypertension: hemodynamic and antihypertensive effects. Celentano A; Galderisi M; Tammaro P; Mureddu GF; Garofalo M; de Simone G; de Divitiis O Int J Clin Pharmacol Ther Toxicol; 1991 Dec; 29(12):494-8. PubMed ID: 1839903 [TBL] [Abstract][Full Text] [Related]
6. Alpha 1-adrenoreceptor blockade in hypertension: pharmacological and clinical profile of doxazosin. Proceedings of an international symposium. Venice, Italy, 14 June 1985. Br J Clin Pharmacol; 1986; 21 Suppl 1():1S-92S. PubMed ID: 2939864 [No Abstract] [Full Text] [Related]
7. Antihypertensive effect of amlodipine compared with nifedipine retard in patients with mild and moderate essential hypertension. Kalina Z; Okopień B; Madej A; Tokarz D; Maślankiewicz A; Szwed Z; Gross-Furek V; Herman ZS Boll Chim Farm; 1998; 137(7):281-5. PubMed ID: 9795483 [TBL] [Abstract][Full Text] [Related]
8. Prazosin GITS vs sustained release nifedipine in patients with hypertension and abnormal lipid profile: a randomized, controlled, multicenter study. Madras Hypertension Study Group. Misra KP; Joglekar SJ; Mukherjee S; Nanivadekar AS J Assoc Physicians India; 1998; Suppl 1():30-40. PubMed ID: 11233385 [TBL] [Abstract][Full Text] [Related]
9. Dose-response clarification in early drug development. Meredith PA; Elliott HL; Donnelly R; Reid JL J Hypertens Suppl; 1991 Dec; 9(6):S356-7. PubMed ID: 1840197 [No Abstract] [Full Text] [Related]
10. A symposium: Doxazosin: coronary artery disease risk factor management. June 7, 1986, Frankfurt, Germany. Am J Cardiol; 1987 May; 59(14):1G-104G. PubMed ID: 2954453 [No Abstract] [Full Text] [Related]
11. [Doxazosin and nitrendipine. A double-blind comparative study in patients with mild to moderate hypertension]. Nechwatal W Fortschr Med; 1987 Nov; 105(34):679-82. PubMed ID: 2962918 [No Abstract] [Full Text] [Related]
12. Tolerability of high doses of lercanidipine versus high doses of other dihydropyridines in daily clinical practice: the TOLERANCE Study. Barrios V; Escobar C; de la Figuera M; Llisterri JL; Honorato J; Segura J; Calderón A Cardiovasc Ther; 2008; 26(1):2-9. PubMed ID: 18466416 [TBL] [Abstract][Full Text] [Related]
13. Clinical settings for selective alpha-adrenergic receptor inhibition: rationale and management strategies. Proceedings of a symposium. Naples, Florida, October 13 to 16, 1988. Am J Med; 1989 Aug; 87(2A):1S-66S. PubMed ID: 2569821 [No Abstract] [Full Text] [Related]
16. [Clinical trial with isradipine in the treatment of mild and moderate arterial hypertension]. Miguel JM; Nunes AC; Gonçalves FR; Pêgo GM Rev Port Cardiol; 1991 Dec; 10(12):931-9. PubMed ID: 1839656 [TBL] [Abstract][Full Text] [Related]
17. [Doxazosin for the treatment of arterial hypertension]. Mozzato MG; Semplicini A; Serena L; Valle R; Casolino P; Buzzaccarini F; Rubino N; Giusto M; Pessina AC Cardiologia; 1990 Nov; 35(11):931-6. PubMed ID: 2151571 [TBL] [Abstract][Full Text] [Related]